• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去溶剂化过程在尼氯柳胺通道溶剂合物中的作用。

Desolvation Processes in Channel Solvates of Niclosamide.

机构信息

Department of Chemistry, Georgetown University, 37th and O Streets NW, Washington, District of Columbia 20057-1227, United States.

出版信息

Mol Pharm. 2023 Nov 6;20(11):5554-5562. doi: 10.1021/acs.molpharmaceut.3c00481. Epub 2023 Oct 18.

DOI:10.1021/acs.molpharmaceut.3c00481
PMID:37850910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10630950/
Abstract

The antiparasitic drug niclosamide (NCL) is notable for its ability to crystallize in multiple 1:1 channel solvate forms, none of which are isostructural. Here, using a combination of time-resolved synchrotron powder X-ray diffraction and thermogravimetry, the process-induced desolvation mechanisms of methanol and acetonitrile solvates are investigated. Structural changes in both solvates follow a complicated molecular-level trajectory characterized by a sudden shift in lattice parameters several degrees below the temperature where the desolvated phase first appears. Model fitting of kinetic data obtained under isothermal heating conditions suggests that the desolvation is rate-limited by the nucleation of the solvent-free product. The desolvation pathways identified in these systems stand in contrast to previous investigations of the NCL channel hydrate, where water loss by diffusion initially yields an anhydrous isomorph that converts to the thermodynamic polymorph at significantly higher temperatures. Taking the view that each solvate lattice is a unique "pre-organized" precursor, a comparison of the pathways from different starting topologies to the same final product provides the opportunity to reevaluate assumptions of how various factors (e.g., solvent binding strength, density) influence solid-state desolvation processes.

摘要

抗寄生虫药物硝氯酚(NCL)的一个显著特点是能够以多种 1:1 通道溶剂化物形式结晶,这些形式均非同构。在这里,我们使用时间分辨同步加速器粉末 X 射线衍射和热重分析相结合的方法,研究了甲醇和乙腈溶剂化物的过程诱导去溶剂化机制。两种溶剂化物的结构变化都遵循一个复杂的分子水平轨迹,其特征是在首先出现去溶剂化相的温度以下几度处晶格参数突然发生变化。在等温加热条件下获得的动力学数据的模型拟合表明,去溶剂化过程受到无溶剂产物成核的速率限制。在这些体系中确定的去溶剂化途径与之前对 NCL 通道水合物的研究形成对比,在之前的研究中,水通过扩散损失首先产生无水同构物,然后在更高的温度下转化为热力学多晶型物。从每个溶剂化物晶格都是独特的“预组织”前体的角度来看,比较不同起始拓扑结构到相同最终产物的途径,为重新评估各种因素(例如溶剂结合强度、密度)如何影响固态去溶剂化过程提供了机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/6c5280ae5a1d/mp3c00481_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/0ddb4c705b1e/mp3c00481_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/a5ff0c361bcb/mp3c00481_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/d7dd880ac529/mp3c00481_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/56f585e3305d/mp3c00481_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/7c42b258fcf8/mp3c00481_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/e5c3a009a265/mp3c00481_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/f16ae4d4f0ba/mp3c00481_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/6c5280ae5a1d/mp3c00481_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/0ddb4c705b1e/mp3c00481_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/a5ff0c361bcb/mp3c00481_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/d7dd880ac529/mp3c00481_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/56f585e3305d/mp3c00481_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/7c42b258fcf8/mp3c00481_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/e5c3a009a265/mp3c00481_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/f16ae4d4f0ba/mp3c00481_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eab6/10630950/6c5280ae5a1d/mp3c00481_0008.jpg

相似文献

1
Desolvation Processes in Channel Solvates of Niclosamide.去溶剂化过程在尼氯柳胺通道溶剂合物中的作用。
Mol Pharm. 2023 Nov 6;20(11):5554-5562. doi: 10.1021/acs.molpharmaceut.3c00481. Epub 2023 Oct 18.
2
Niclosamide methanol solvate and niclosamide hydrate: structure, solvent inclusion mode and implications for properties.氯硝柳胺甲醇溶剂合物和氯硝柳胺水合物:结构、溶剂包合模式及其对性质的影响
Acta Crystallogr C Struct Chem. 2014 Aug;70(Pt 8):758-63. doi: 10.1107/S2053229614015496. Epub 2014 Jul 10.
3
Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate.5种氯硝柳胺溶剂化物和1种半溶剂化物的制备及物理化学表征
AAPS PharmSciTech. 2004 Feb 23;5(1):E12. doi: 10.1208/pt050112.
4
Olanzapine solvates.奥氮平溶剂化物。
J Pharm Sci. 2013 Nov;102(11):4046-56. doi: 10.1002/jps.23714. Epub 2013 Aug 20.
5
Expanding the structural landscape of niclosamide: a high Z' polymorph, two new solvates and monohydrate H(A).拓展氯硝柳胺的结构格局:一种高Z'多晶型物、两种新溶剂化物和一水合物H(A)。
Acta Crystallogr C Struct Chem. 2015 May;71(Pt 5):394-401. doi: 10.1107/S2053229615005847. Epub 2015 Apr 15.
6
Organic vapor sorption method of isostructural solvates and polymorph of tenofovir disoproxil fumarate.富马酸替诺福韦二异丙酯的同晶型溶剂化物和多晶型的有机蒸汽吸附法。
Eur J Pharm Sci. 2013 Nov 20;50(3-4):253-62. doi: 10.1016/j.ejps.2013.07.004. Epub 2013 Jul 18.
7
A multi-technique approach to the study of structural stability and desolvation of two unusual channel hydrate solvates of finasteride.采用多种技术手段研究非寻常通道型水合物溶剂化物中依普利酮的结构稳定性和去溶剂化作用。
J Pharm Sci. 2012 Jan;101(1):176-86. doi: 10.1002/jps.22740. Epub 2011 Sep 9.
8
Structure and thermal stability of alprazolam and selected solvates.阿普唑仑及其选定溶剂化物的结构与热稳定性
J Pharm Sci. 1995 Nov;84(11):1379-84. doi: 10.1002/jps.2600841121.
9
Comparison between dehydration and desolvation kinetics of fluconazole monohydrate and fluconazole ethylacetate solvate using three different methods.使用三种不同方法比较氟康唑一水合物和氟康唑乙酸乙酯溶剂化物的脱水和解溶剂化动力学。
J Pharm Sci. 2006 Apr;95(4):859-70. doi: 10.1002/jps.20605.
10
Comparison of the physical and chemical stability of niclosamide crystal forms in aqueous versus nonaqueous suspensions.氯硝柳胺晶型在水相悬浮液与非水相悬浮液中的物理和化学稳定性比较。
Drug Dev Ind Pharm. 2004 Jul;30(6):581-92. doi: 10.1081/ddc-120037489.

本文引用的文献

1
Dehydration of Niclosamide Monohydrate Polymorphs: Different Mechanistic Pathways to the Same Product.氯硝柳胺一水合物多晶型物的脱水:通往相同产物的不同机理途径。
Cryst Growth Des. 2023 Jun 2;23(7):5102-5111. doi: 10.1021/acs.cgd.3c00322. eCollection 2023 Jul 5.
2
Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19.氯硝柳胺作为抗新冠病毒药物的可能作用机制。
Med Hypotheses. 2020 Apr 22;140:109765. doi: 10.1016/j.mehy.2020.109765.
3
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
广谱抗病毒药物氯硝柳胺及其治疗潜力。
ACS Infect Dis. 2020 May 8;6(5):909-915. doi: 10.1021/acsinfecdis.0c00052. Epub 2020 Mar 10.
4
: from visualization to analysis, design and prediction.从可视化到分析、设计与预测。
J Appl Crystallogr. 2020 Feb 1;53(Pt 1):226-235. doi: 10.1107/S1600576719014092.
5
A Prolific Solvate Former, Galunisertib, under the Pressure of Crystal Structure Prediction, Produces Ten Diverse Polymorphs.高产溶剂化物形成剂 galunisertib 在晶体结构预测的压力下产生十种不同的多晶型物。
J Am Chem Soc. 2019 Sep 4;141(35):13887-13897. doi: 10.1021/jacs.9b06634. Epub 2019 Aug 21.
6
Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).尼拉帕尼对整合的 HIV-1 和结核分枝杆菌(北京)复制的双重抑制作用。
Tuberculosis (Edinb). 2019 May;116S:S28-S33. doi: 10.1016/j.tube.2019.04.008. Epub 2019 Apr 25.
7
Solid-State Insight Into the Action of a Pharmaceutical Solvate: Structural, Thermal, and Dissolution Analysis of Indinavir Sulfate Ethanolate.固态深入了解药用溶剂化物的作用:硫酸茚地那韦乙醇酸盐的结构、热分析和溶解分析。
J Pharm Sci. 2018 Oct;107(10):2731-2734. doi: 10.1016/j.xphs.2018.06.020. Epub 2018 Jun 28.
8
Niclosamide: Beyond an antihelminthic drug.尼氯硝唑:超越抗蠕虫药物。
Cell Signal. 2018 Jan;41:89-96. doi: 10.1016/j.cellsig.2017.04.001. Epub 2017 Apr 4.
9
Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals.药物溶剂化物、水合物和无定形形式:特别关注共晶。
Adv Drug Deliv Rev. 2017 Aug 1;117:25-46. doi: 10.1016/j.addr.2017.03.002. Epub 2017 Mar 22.
10
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.通过药物再利用筛选鉴定寨卡病毒感染及诱导神经细胞死亡的小分子抑制剂。
Nat Med. 2016 Oct;22(10):1101-1107. doi: 10.1038/nm.4184. Epub 2016 Aug 29.